The present invention provides a long circulating non-pegylated liposomal doxorubicin hydrochloride composition for parenteral administration and a process for its preparation. Receiving the encoded transmission and converting the first portion into digital information having a predetermined format. 60 dlg, and contains fillers having filler diameters of from 10 to 500 nm at a filler density of from 1100 to 50100 \u03bcm2. The lead has electrodes placed about a perimeter. This prevents the lubricant from reducing the traction capability of the drive wheels of the next oncoming locomotive.